Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
EGFR inhibitor.
Peptide, vasopressin analog; V1/2 agonist.
5-HT2A and TRPV1 antagonist, potential α1-adre...
BUB1 inhibitor.
Multikinase inhibitor.
GABA analog; GABA potentiator, adenosine A1 ago...
Mycotoxin produced by species of Aspergillus; D...
Flavonoid found in Epimedium sagittatum.
Roscovitine analog; CDK inhibitor.
beta-catenin inhibitor
H+/K+ ATPase and ROCK-2 inhibitor.
Thienylbutyl ITC analog.
Acyl transfer catalyst, involved in peptide syn...
SIRT1/2 inhibitor.
An omega-3 fatty acid.
Benzothiazepine; L-type Ca2+ channel blocker, p...
Peptide, derivative of AT I, cleavage product o...
Synthetic derivative of selenocyanate.
Aspartyl protease inhibitor.
Found in Evodia rutaecarpa; potential cAMP, 3β...